Introduction
Critical limb ischemia causes substantial morbidity and mortality. Despite advances in surgical and endovascular techniques, it is estimated that 150 000 patients per year require lower limb amputations due to critical limb ischemia in the United States. 1 Developing an effective gene therapy to promote collateral artery development and increase blood flow to critically ischemic limbs would be of considerable clinical value.
The endothelial isoform of nitric oxide synthase (eNOS) is one of three isoenzymes that converts L-arginine to L-citrulline and nitric oxide (NO). NO, a potent vasodilator and anti-inflammatory agent, plays an important role in both collateral artery development and angiogenesis in vivo. [2] [3] [4] NO regulates blood pressure, platelet aggregation, leukocyte adhesion, and smooth muscle mitogenesis. [5] [6] [7] [8] [9] [10] [11] [12] Several key angiogenic factors, including FGF, VEGF, angiotensin II, nerve growth factor, TNF-a, and platelet activating factor 4, have been found to act via NO. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] Adenovirus-mediated overexpression of eNOS (Ade-NOS) has been shown to increase significantly collateral artery development, leading to increased limb blood flow in a rat model of hindlimb ischemia. [28] [29] [30] In contrast, eNOS deficiency can decrease angiogenesis. [31] [32] [33] [34] [35] In order to realize the promise of adenovirus-mediated eNOS (AdeNOS) overexpression to treat critical limb ischemia, the most effective and safest method of gene delivery must be established first. In this study, we chose three different delivery techniques for AdeNOS: intraarterial under vascular isolation (intra-arterial with tourniquet), intra-arterial under transient arterial and venous occlusion (intra-arterial without tourniquet), and intramuscular injection. We hypothesized that intra-arterial delivery under vascular isolation would achieve the highest rate of gene transfer and the lowest rate of transgene expression in systemic organs based on our previous experience with this technique. 36 However, this technique is relatively invasive and also may cause increased tissue injury secondary to effects from the tourniquet. We therefore tested a less invasive intraarterial technique, intra-arterial delivery under transient arterial and venous occlusion, recognizing that transduction of distant organs was likely to be higher than that under vascular isolation. Lastly, we tested intramuscular delivery, the simplest and least invasive technique, and the technique that experimentally has been the most widely studied. We performed a systematic comparison of the effects of these three techniques of AdeNOS delivery on limb blood-flow, collateral artery development, capillary angiogenesis, clinical ischemic index, 37 muscle mass and architecture, and transgene expression in distant organs.
Results

Local and systemic transgene expression
We compared the differences in the extent and location of transgene expression by performing RT-PCR, lacZ whole-mount staining, and eNOS immunohistochemistry on harvested muscles and organs 4 days after adenoviral gene transfer using the three different techniques (Figure 1 ). After intra-arterial delivery, RT-PCR results showed transgene expression primarily in the calf muscles (mainly in the gastrocnemius muscle, lower expression in the tibialis anterior muscle), with some expression in the thigh muscles (biceps femoris, gracilis, quadriceps). This expression pattern corresponded with previously published results from our laboratory. 36 The transgene was also expressed in the contralateral limb after intra-arterial delivery techniques in the vascular isolation group. Minimal transgene was expressed in the brain, heart, lung, liver, spleen, kidney, or testis in either intra-arterial group (Figure 1c) .
After intramuscular delivery, substantially less transgene was expressed in gastrocnemius muscles than that after intra-arterial delivery as detected by RT-PCR (Figure 1c ), lacZ staining (Figure 1b) , and immunohistochemical staining for eNOS (Figure 1a) . We also performed semiquantitative analysis for gene expression in the left gastrocnemius. Our results show that after intra-arterial injection, AdLacZ expression was six-to seven-fold higher than intramuscular injection ( Figure  1d ). Equivalent levels of transgene were detected in the tibialis anterior muscle after the three different delivery techniques. Minimal expression was found in the brain, liver, and testis ( Figure 1c ). Intramuscular delivery of AdeNOS, AdLacZ, or phosphate-buffered saline (PBS) by any technique did not result in contralateral limb expression. eNOS transgene expression was detected up to 14 days after injection, but not at 21 days by immunostaining (data not shown). ]citrulline in the presence and absence of calcium. The eNOS activity was significantly higher in the groups received AdeNOS by intra-arterial techniques than after either intramuscular delivery or PBS control groups. Intramusular delivery also increased eNOS activity when compared with values with PBS control (Figure 2 ). (Figure 3d ). Although intramuscular delivery of AdeNOS increased blood flow less than did intra-arterial delivery, it did increase blood flow recovery more than delivery of PBS or AdlacZ (Po0.01) (Figure 3c ). There was no significant difference between blood flow recovery after delivery of PBS or AdlacZ; thus, the delivery of modified adenovirus had no effect on the recovery of hindlimb blood-flow.
Histopathology of ischemic hindlimb muscle. After delivery of PBS, hematoxylin and eosin (HE) staining of hindlimb muscle showed necrotic and regenerating myocytes (central nuclei) as well as inflammatory cell infiltrates 30 days (Figure 4a ). In contrast, eNOS overexpression resulted in less inflammatory cell infiltration and near-normal muscle architecture (Figure 4a ). Recovery of muscle architecture correlated with the extent of eNOS gene transfer; thus, intra-arterial delivery resulted in more normal muscle architecture than did intramuscular delivery.
Muscle mass. After critical hindlimb ischemia, both the calf and thigh musculature of the rat hindlimb atrophy. Delivery of AdeNOS reversed this atrophy and led to recovery of muscle mass to near normal levels by 30 days. Both intra-arterial delivery techniques of AdeNOS increased muscle mass recovery significantly more than did intramuscular delivery of AdeNOS (Po0.01), PBS (Po0.001), or AdlacZ (Po0.001) in calf muscle. Again, muscle mass recovery correlated with the extent of eNOS gene transfer (Table 1) ; thus, intra-arterial delivery resulted in higher muscle mass than intramuscular delivery, which resulted in higher muscle mass than delivery of either PBS or AdlacZ.
Clinical ischemic index. By 30 days after intra-aterial injection of AdeNOS, the rats' feet and calves appeared almost normal (Figure 4b ). Their gait also had returned almost to normal. However, after intramuscular AdeNOS injection, the calf and foot muscles still showed atrophy, and the rats walked with an abnormal gait. Muscle atrophy and gait abnormalities were worst in rats that received either PBS or AdlacZ.
Capillary density and capillary/muscle fiber ratio. To further evaluate the effects of different eNOS delivery techniques on capillary angiogenesis, CD31 staining was performed on gastrocnemius muscle. AdeNOS delivery by intra-arterial injection produced significantly stronger CD31 staining and higher capillary/muscle fiber ratios (1.7970.05 IA+T, 1.7870.07 IAÀT) than did intramuscular eNOS (1.3670.01, Po0.05), PBS (0.6470.07, Po0.001) ( Figure 5 ). Intramuscular delivery of AdeNOS also increased angiogenesis (Po0.01 versus PBS and AdlacZ), although to a lesser degree than did intraarterial delivery.
Angiography. Collateral artery development of the ischemic limb was significantly increased in all groups after AdeNOS delivery ( Figure 6a ). Intra-arterial delivery induced more collateral artery development than did intramuscular delivery (Po0.05). Angioscores were consistant with the degree of eNOS gene transfer (Figure 6b ).
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Discussion
This study shows that intra-arterial AdeNOS delivery under vascular isolation achieves the highest rate of ischemic leg blood flow recovery and gene transfer, while causing the least level of muscle damage measured in a variety of ways in a rat model of hindlimb ischemia. Analysis of regional transgene expression showed that intra-arterial injection was significantly more efficient than intramuscular injection. Consequently, eNOS activity was greatly increased after both techniques of intraarterial AdeNOS delivery than after intramuscular AdeNOS delivery or PBS control groups. There was no significant difference in eNOS activity, blood flow recovery or in the extent of transgene expression between either intra-arterial delivery technique, but delivery under transient vascular occlusion caused less muscle damage and greater recovery of muscle mass than did delivery under vascular isolation. Intramuscular injection showed the lowest level of transgene expression, blood flow recovery and muscle mass of the three gene delivery techniques. Intramuscular and, to a much lesser extent, intraarterial gene delivery are commonly used for transgene delivery in vascular disease. 36, [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] Vajanto et al 47 demonstrated that intramuscular administration of AdVEGF Calcium-dependent eNOS activity in gastrocnemius muscle was significantly higher in all groups receiving AdeNOS than in PBS group. Although no significant difference was found between the two intraarterial delivery techniques, both of the intra-arterial delivery techniques caused a significantly higher eNOS activity than did the intramuscular gene delivery technique. n ¼ 6. *Po0.001 versus PBS; # Po0.01 versus AdeNOS+IM, Â Po0.05 versus PBS.
Optimization of adenovirus-mediated eNOS J Yan et al into ischemic rabbit skeletal muscle resulted efficient gene transfer and induced angiogenesis. Similarly, intramuscular delivery of AdeNOS in rat hindlimb ischemia model also led to significant increases in blood perfusion and angiogenesis. In that study, eNOS transgene expression could be identified 1 week after gene transfer and could still be weakly detected 4 weeks after injection. 29 Isner et al showed that after arterial gene Optimization of adenovirus-mediated eNOS J Yan et al transfer of phVEGF165 in patients with ischemic limbs in collateral arteries at the knee, mid-tibial, and ankle levels increased. Our previous study also showed that intraarterial delivery of adenovirus encoding interleukin-1 to the rat hindlimb under vascular isolation led to high rates of gene transfer to the gastrocnemius capillary endothelium and muscle fiber of 7177 and 2575% transduction rate, respectively. 36 However, intra-arterial and intramuscular adenovirus-mediated gene transfer have not been compared in terms of efficiency, safety or efficacy. Therefore, we focused on a systematic comparison between intra-arterial and intramuscular delivery of AdeNOS for the reversal of hindlimb ischemia in rats.
In animal models of hindlimb ischemia, the arteries will remodel themselves in response to a variety of stimuli, including hemodynamic forces (shear rate) and tissue metabolic demands (ischemia). Two different processes, 'angiogenesis' (or creation of capillaries) and 'arteriogenesis' (or growth and development of preexisting collateral arteries) are involved in vascular remodeling. The key role that eNOS plays in angiogenesis and arteriogenesis of hindlimb ischemia has been demonstrated in both in vitro and in vivo experiments. 4 ) show reduced vascular endothelial growth factor (VEGF)-induced mobilization of endothelial progenitor cells (EPCs) and increased mortality after myelosuppression. Progenitor mobilization from the bone marrow is also impaired in NOS3 À/À mice. These studies provide evidence that eNOS is a critical molecule for angiogenesis and arteriogenesis in vivo in response to tissue ischemia. In our experiments, we have provided further evidence that eNOS overexpression greatly increases blood flow recovery of ischemic leg due to increased angiogenesis (capillaries per skeletal muscle fiber) and arteriogenesis (angioscore), especially after intra-arterial delivery. We found that 30 days Optimization of adenovirus-mediated eNOS J Yan et al after intra-arterial delivery of AdeNOS in rats, the blood flow of ischemic hindlimb almost normalized. Intra-arterial delivery of eNOS led to greater angiogenesis and restoration of muscle mass than did intramuscular delivery.
We have validated the measurement of the major dependent variables used in this study in prior experiments. 30, 36, 37, 49 In particular, blood flow measurement by microspheres, direct tissue O 2 determination, and laser Doppler correlated well with one another. However, laser Doppler has limitations and must be applied in a rigorous manner. This includes being aware of the type and level of anesthetic used for blood flow measurements, the need to maintain rigorous control of body temperature, and the recognizability that the laser Doppler only penetrates to a depth of 1 mm and thus largely reflects changes in skin blood flow. Nonetheless, when applied properly, we believe laser Doppler represents an accurate though not precise estimation of hind limb blood flow.
There have not been, to our knowledge, any prior systemic comparisons of gene delivery techniques used to reverse experimental hindlimb ischemia. In this regard, the results of this study suggest that adenovirus mediated gene transfer in human could be accomplished by a relatively simple and less invasive manner. A balloon catheter could be introduced into the artery and vein of the affected limb. Both balloons could be inflated 
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and an appropriate volume and concentration of AdeNOS could be injected into the arterial catheter. After 30 min, the balloons could be deflated, and the catheters removed. Vascular isolation of a chronically ischemic human leg by inflation of a blood pressure cuff over the proximal thigh may prove to be less injurious than it has been in small animal models such as those used in this study.
In conclusion, this study shows that intra-arterial delivery of AdeNOS under transient venous and arterial occlusion results in the most efficient level of gene transfer and the best therapeutic effect by measurement of blood flow, collateral artery development, and reversal of muscle atrophy. Intra-arterial delivery may be the optimal technique to overexpress eNOS in human ischemic limbs to reverse the devastating effect of critical limb ischemia.
Materials and methods
Rat hindlimb ischemia model
Adult male Sprague-Dawley rats (270-300 g), purchased from Charles River, were housed in an environmentally controlled room and given chow and water ad libitum. After induction of 2% isoflurane inhalational anesthesia, left hindlimb ischemia was induced by ligation of the left common iliac, internal and external iliac, and superficial femoral arteries and associated branches as described previously. 37 The care of animals complied with the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC, National Academy Press, 1996). All protocols were approved in accordance with the Committee on Animal Research at the University of California San Francisco.
Preparation of recombinant adenoviruses
Adenoviral recombinants encoding LacZ or bovine eNOS cDNA driven by the Rous sarcoma virus promoter, 50 generous gifts from Dr Beverly Davidson (University of Iowa College of Medicine), were propagated and titrated by 293 cells as described previously. 49 All adenovirus stock was stored at À801C, then thawed immediately before use, and diluted in PBS to achieve a final concentration of 1 Â 10 10 plaque forming units (PFU)/ml.
Study design
Rats were randomly divided into nine treatment groups of nine rats each as follows: AdeNOS, AdlacZ, or PBS delivered intra-arterially under vascular isolation (Ade-NOS+T, AdlacZ+T, or PBS+T, respectively), AdeNOS, AdlacZ, or PBS delivered intra-arterially under transient vascular occlusion (AdeNOS-T, AdlacZ-T, or PBS-T respectively), and AdeNOS, AdlacZ, or PBS delivered intramuscularly into the calf (AdeNOS+M, AdlacZ+M, or PBS+M, respectively). All rats in all groups underwent surgically created hindlimb ischemia 10 days prior to gene delivery. Three rats per group were killed at 4 days after gene delivery for analysis of transgene expression by immunohistochemistry, lacZ staining, and RT-PCR. The remaining six rats per group underwent laser Doppler perfusion imaging pre-and postgene transfer, and at 4, 14, 21, and 30 days after gene delivery. A clinical ischemia index and angiograms were obtained prior to killing at 30 days. Muscles were harvested and weighed at killing, and then processed histopathologically and immunohistochemically for capillary-to-muscle-fiber ratio analysis.
Gene delivery techniques Intra-arterial delivery under vascular isolation (intraarterial with tourniquet). Intra-arterial delivery of AdeNOS under vascular isolation was performed as previously described. 30, 36 Briefly, a tourniquet was placed on the proximal thigh after isolation of the common femoral artery, vein, and nerve to prevent collateral inflow or outflow. The saphenous artery was ligated and cannulated in a retrograde manner with a 30G needle. After the femoral vein and the proximal saphenous vein were clamped with microvascular clamps, a venotomy was made in the distal saphenous vein to serve as outflow for flushing the hindlimb vasculature. Warm heparinized sodium (10 ml at 100 U/ml) was injected, followed by 5 ml of PBS. The venotomy was temporarily clamped, and 1 Â 10 10 PFU/ ml of AdeNOS, AdlacZ, or PBS (sham) was subsequently infused in a total volume of 0.7 ml and allowed to dwell for 30 min. Any residual virus vector was flushed out of the saphenous venotomy by using 5 ml of PBS, after which the saphenous vein and artery were ligated.
Intra-arterial delivery under temporary vascular occlusion (intra-arterial without tourniquet). Intra-arterial delivery under temporary vascular occlusion was performed as above, except that the tourniquet to eliminate collateral inflow or outflow was omitted, and the hindlimb vasculature was not flushed out prior to or after delivery of vector.
Intramuscular delivery. A small skin incision was made to expose the site of intramuscular delivery. AdeNOS, AdlacZ or PBS at 1 Â 10 10 PFU/ml was injected using a 28G needle into the tibialis anterior muscle (100 ml) and the gastrocnemius muscle (200 ml into each of the medial, lateral, and central muscle bellies).
Laser Doppler perfusion imaging of hindlimb blood flow
Rats were anesthetized using 1% isoflurane with a 1 l/min O 2 flow rate. Their hindlimbs were shaved and then depilated using Surgiprep depilatory cream. The rats were put on a homeothermic heating pad and allowed to equilibrate to a rectal temperature of 371C. Laser Doppler perfusion imaging was then performed over the legs and feet by using a laser Doppler perfusion imager (Moor LDI; Moor instruments, Devon, UK). The same area of interest (bilateral leg and foot) was scanned three times, and the results were averaged. To avoid data variations due to ambient light and temperature, hindlimb blood flow was analyzed as a ratio of left (ischemic) to right (nonischemic).
Angiograms
Rats were anesthetized using 1% isoflurane with a 1 l/min O 2 flow rate. The infrarenal abdominal aorta was isolated and then ligated proximally and clamped distally. A 20G polyethylene catheter was used to cannulate the aorta, the distal clamp was removed, and
Optimization of adenovirus-mediated eNOS J Yan et al 2.5 ml heparinized saline (10 U/ml) was injected, followed by 2.5 ml contrast medium (EZPaque, Merry X-Ray, South San Francisco, CA, USA). The aorta and inferior vena cava were then ligated. The skin was removed from the hindlimbs to prevent imaging of the dermal vasculature. Images were taken by using a single developed Kodak X-OMAT TL film at 500 mA, 50 kV, and 0.5 s exposure. Angioscores were derived by placing a grid over the angiogram in the region of the greater trochanter to the patella. Three blinded observers counted the number of contrast-opacified arteries crossing over the gridlines and the total number of lines encompassing the region of interest. The angioscore was calculated as the ratio of overlying opacified arteries divided by the total number of lines in the region of interest.
Tissue preparation
Tibialis anterior muscle (TA), gastrocnemius muscle (GC), biceps femoris (BF), gracilis (Gr), quadreps (Q), brain, heart, lung, liver, spleen, kidney, testis were harvested and weighed. Middle sections of the gastrocnemius muscle were either preserved in O.C.T. compound (Tissue-Tek, Fisher Scientific, Fairlawn, NJ, USA) and cooled in dry-ice liquid pentane slush for frozen sections or fixed in 1.5% glutaraldehyde for 3 h for lacZ staining. The remainder of the gastrocnemius and all other tissues were snap-frozen in liquid nitrogen for later harvest of RNA for use in RT-PCR.
Histopathology
In total, 10-mm-thick frozen gastrocnemius muscle sections were stained with Gills HE, and the muscles were studied to determine qualitatively the extent of damage to the muscle architecture, edema, and inflammatory cell infiltration in the different experimental groups.
LacZ staining
Gastrocnemius muscle was cut into 100 mm sections using a vibratome (VT 1000 S, Leica, Lafayette, California). Muscles were stained overnight with 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal) solution (1 mg/ml X-gal, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 2 mM magnesium chloride, 0.02% NP40 and PBS) at room temperature.
Immunohistochemistry
In total, 10-mm-thick transverse frozen sections of tissue samples were used for immunohistochemical analysis. Transgene eNOS expression was detected using a mouse anti-human eNOS monoclonal antibody that specifically stains transgene eNOS, but not endogenous rat eNOS (BD Biosciences, San Diego, CA, USA, 1:50 dilution). Capillary-to-muscle fiber ratios were determined by staining endothelial cells for platelet endothelial cell adhesion molecule-1 (PECAM-1, CD31) using a mouse anti-rat PECAM-1 monoclonal antibody (Serotec, Raleigh, NC, USA, 1:500 dilution) as previously described. 37 The secondary antibody for all staining was horse anti-mouse monoclonal antibody, rat adsorbed (Vector Laboratories, Burlingame, CA, USA, 1:250 dilution). Negative controls were created by substituting blocking buffer for primary antibody. Antibody staining was detected by using the Vectastain ABC kit followed by the Vectastain DAB kit (Vector Laboratories, Inc., Burlingame, CA, USA) as per the manufacturer's instructions.
RT-PCR
Total RNA was extracted from frozen tissue by homogenization in 1 ml of Trizol solution (Invitrogen, Carlsbad, CA, USA); 2 mg of RNA was used for reverse transcription. The cDNA was amplified by PCR for 40 cycles (941C for 3 min, 941C for 30 s, 571C for 30 s, 721C  for PCR products were electrophoresed on a 1% agarose gel and visualized by using ethidium bromide.
Measurement of eNOS activity
eNOS activty in the gastrocnemius muscle was measured 4 day after gene transfer of eNOS (Calbiochem, San Diego, CA, USA). The rats were killed and the gastrocnemius muscles were excised and snap-frozen in liquid nitrogen. To extract total protein, the muscles were homogenized in ice-cold buffer (250 mM Tris-HCl, pH 7.4, 10 mM EDTA, 10 mM EGTA) and centrifuged at 14 000 r.p.m. for 5 min. The supernatant was transferred to another microtube, then protein concentration was measured with BCA protein assay reagent (Pierce, Rockford, IL, USA) and diluted to the final concentration of 5 mg/ml. A measure of 10 ml protein reagent was incubated in 10 mM NADPH 1 mCi/ml 14 C-arginine/ 6 mM CaCl 2 /50 mM Tris HCl, pH 7.4/6 mM tetrahydrobiopterin/2 mM FAD/2 mM FMN for 30 min at 371C. The reaction was stopped with 50 mM HEPES, pH 5.5/5 mM EDTA. Identical samples were prepared without CaCl 2 to determine the amount of calcium-dependent NOS activity. All samples were run in duplicates. The calciumdependent NOS activity was calculated by subtracting the NOS activity measured without calcium. The radioactivity of the sample eluate was measured by liquid scincillation. Enzyme activity was expressed as counts per minutes per microgram (CPM/mg).
Clinical ischemia index
On postinjection day 30, we assessed the degree of ischemia based on the presence or absence of pressure sores, gangrene, or atrophy, and observed the rat's gait as previously described. 37 Digital pictures of the rats' hindlimbs were taken to document signs of ischemia.
Statistical analysis
Data were presented as mean7s.d. Analysis of variance (ANOVA) was performed for multiple comparisons among different groups, followed by post hoc analysis using the Student-Newman-Keuls test. Differences with a P-value less than 0.05 were considered statistically significant.
